phase i dose-escalation study of the bet inhibitor incb057643 in r/r myelofibrosis
Published 1 year ago • 183 plays • Length 1:52Download video MP4
Download video MP3
Similar videos
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:49
phase ii trial-in-progress of itacitinib in patients with myelofibrosis
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
4:43
phase ib trial of ianalumab plus ibrutinib for cll
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
21:11
how to write ib myp science criterion c - processing and evaluating?
-
11:44
developments in microscopy - a2.2.3
-
![[ib biology topic 1 revision] introduction to cells](https://i.ytimg.com/vi/7mZH_CiMrWI/mqdefault.jpg)
13:51
[ib biology topic 1 revision] introduction to cells
-
43:51
incorporating biomarkers in phase i clinical trials - contribution to phase ii and iii (中文)
-
1:58
transfusion-independence associated with os in simplify-1 and simplfy-2
-
2:08:41
21 dec 2022 - hematology master class - iof webinar
-
3:38
bosutinib in the second-line setting
-
2:13
explore bio sb's fast mohs ihc
-
8:32
idot tutorial
-
1:17
the balance between bleeding and clotting | research in a minute | versiti